Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Ethypharm SA
Ethypharm SA
X
LinkedIn
Trending Articles
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
COVID-19 still a significant risk for the immunocompromised, study finds
AstraZeneca's INFORM study highlights the persistent danger of COVID-19 for the immunocompromised despite the vaccination scheme
US court lifts modified consent decree on Xellia’s Cleveland facility
The Modified Consent Decree imposed on Xellia's Cleveland facility in 2016 has been vacated, receiving a VAI
Lonza's AI-enabled small molecule development tool launches
The company's AI-enabled Route Scouting Service will optimise synthetic route identification when identifying novel APIs
Autoscribe Informatics’ new Australia office supports business growth
The company's move to West Lakes Adelaide expands its ability to service the Asia Pacific region in digitalising laboratory information
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Regulatory
Ethypharm and RSSL partnership fast-tracks priority medicine
Ethypharm has collaborated with RSSL to accelerate the manufacture and batch release of fentanyl injection
Drug Delivery
French Ethypharm acquires Martindale Pharma
Independent pharmaceutical company Ethypharm reinforces its UK presence by acquiring Martindale Pharma
Finance
Ethypharm acquires DB Ashbourne in the UK
Acquisition will generate a turnover of more than €240m for Ethypharm
Ingredients
Colorcon acquires French excipient firm NP Pharm
Colorcon Inc has expanded its excipient product offerings with the acquisition of NP Pharm
Subscribe now